Percutaneous Treatment of Valvular Heart Disease, Atrial Fibrillation Examined in Various Studies

Article Information

DOI 
http://dx.doi.org/10.1177/1559897715583650
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2015 SAGE Publications

Author Information

  1. Alla Zarifyan
  1. Michael Mack, MD
    1. The Heart Hospital Baylor Plano, Plano, Texas, USA
  2. Michael J. Reardon, MD
    1. Houston Methodist Hospital, Houston, Texas, USA
  3. Paul Sorajja, MD
    1. Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minnesota, USA
  4. Luigi Di Biase, MD, PhD
    1. Texas Cardiac Arrhythmia Institute at St David’s Medical Center, Austin, Texas, USA, and Montefiore Medical Center, Bronx, New York, USA
View Full Text

Article usage

AbstractFullPDF
Apr 20151320
May 2015500
Jun 20151500
Jul 2015600
Aug 20151211
Sep 20157100
Oct 2015233
Nov 20154300
Total16764

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Percutaneous Treatment of Valvular Heart Disease, Atrial Fibrillation Examined in Various Studies
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

AATAC-AF
amiodarone
catheter ablation
CoreValve US Pivotal Trial
PARTNER 1
surgical aortic valve replacement
Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy registry
transcatheter aortic valve replacement
transcatheter mitral valve repair
NCT00530894
NCT01240902
NCT0072991
cardiology & cardiovascular medicine clinical trials
Interventional Techniques & Devices